SOURCES SOUGHT
65 -- CLINICAL LABORATORY CHEMISTRY AND IMMUNOASSAY TESTING SYSTEM
- Notice Date
- 6/22/2017
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of the Air Force, Pacific Air Forces, 374 CONS - Yokota, Unit 5228, Yokota AB, APO Japan, 96328-5228
- ZIP Code
- 96328-5228
- Solicitation Number
- FA520917REAGENTSYOKOTA
- Archive Date
- 8/6/2017
- Point of Contact
- Yuki Watabe, Phone: 81-42-552-3011, Husseina A. Abba, Phone: 81-42-552-3011
- E-Mail Address
-
yuki.watabe.jp@us.af.mil, husseina.abba@us.af.mil
(yuki.watabe.jp@us.af.mil, husseina.abba@us.af.mil)
- Small Business Set-Aside
- N/A
- Description
- This is the source sought, not solicitation, for brand name "VITROS Analyzer Installation", reagents, supplies, training, and maintenance with 24/7 customer support. Unique qualifications of the Contractor or nature of the action: Brand name; Ortho-Clinical Diagnostics is the manufacturer of an integrated chemistry-immunoassay testing analyzers, V itros series 5600 which is in use. The Vitros includes Micro-slide technology which allows it to operate independent of water supply and drainage and provides results with 95 percent reportable result efficiency. The laboratory requires an analyzer with no, or minimal, liquid waste. Since the existing laboratory would not allow changes to the facility infrastructure (i.e. plumbing) beyond minor electrical work or relocation of the laboratory function. A system requiring water requires additional space for unit placement, hard plumbing to facility water sources and to the analyzer, and adds additional man hours to the department for maintenance and decontamination procedures. The Vitros implements the same technology that technicians would utilize in a deployed environment so having it here would assist with annual readiness training requirements. By having the same analyzers the facilities can support each other with emergency transfers of supplies in the following cases: contingency operations, reagent lot issues requiring new lots (ordering supplies from vendors takes a minimum of 24 hrs which can stop patient care throughout the Medical Group) in the event of storage failures that cause reagents to fall out of acceptable ranges. Having the same analyzer allows all sites to send testing to each other in the event of a complete analyzer failure while maintaining the same sample type and reference ranges. Utilizing different values and/or ranges creates a patient safety issue. Furthermore, the use of the same technologies allows for critical quality control and calibration peer review when troubleshooting out-of-range results. Our location and time difference with the U.S. does not allow for quick contacts with other labs sharing the same products to assist in that troubleshooting, which can eliminate the need for technical service. Requirement: The contractor shall provide one (1) fully automated random access chemistry analyzer, capable of performing the chemistry and immunoassay test s listed in Table A1 with a minimum throughput of 150 tests per hour, all sample and calibrator dilutions must be performed automatically. The contractor shall provide all training, supplies, reagents, unscheduled maintenance, and preventive maintenance for the equipment. <ins datetime="2015-06-15T08:39" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB"> All costs will be calculated on reagent rental basis based on the number of patients listed for each Mandatory Test or Desired Test listed in Table A1. Costs shall be amortized over the total number of tests described in this requirement and factored into the cost per reportable or patient billable. <ins datetime="2015-06-14T17:14" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB"> <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">TEST NAME <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">ANNUAL <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">TEST NAME <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">ANNUAL <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Acetaminophen <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">160 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Potassium (k+) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Albumin <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2100 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Lactate <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">40 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Alcohol <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">260 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Lactate Dehydrogenase (LDH) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">370 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Alkaline Phosphatase (ALP) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2100 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Lipase <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">350 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Alanine Aminotransferase (ALT) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2100 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Magnesium <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">240 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Amylase <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">200 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Sodium (Na+) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Aspartate Aminotransferase <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2100 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Phosphorus <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">470 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">beta-HCG <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">450 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Protein-CSF <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">110 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Bilirubin-Conjugated <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">900 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Salicylate <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">160 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Bilirubin-Un-Conjugated <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">900 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Total Bilirubin <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1900 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Cholesterol <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1300 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Total Protein <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1900 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Creatine Kinase (CK) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">430 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Triglycerides <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1240 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Creatine Kinase-MB (CK-MB) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">350 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Thyroid Stimulating Hormone (TSH) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1200 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Creatinine <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Troponin I (cTnI) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">250 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">C-Reactive Protein (CRP) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">450 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Urine Protein <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">160 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Calcium <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Urea <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Chloride (Cl-) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Uric Acid <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">180 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">ECO2 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">2400 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Vancomycin <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">100 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Free Thyroxin (Free T4) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">480 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Hgb A1C <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">580 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Gentamicin <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">70 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">direct High-Density Lipoprotein (dHDL) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1300 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Gamma-Glutamyl Transferase (GGT) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">380 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">direct Low-Density Lipoprotein (dLDL) <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">1300 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">Glucose <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">3000 <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB"> <ins datetime="2015-06-15T14:37" cite="mailto:KIYOTAKA,%20KEISUKE%20JP%20DOD%20PACAF%20374%20CONS/LGCB">
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USAF/PAF/374CONS/FA520917REAGENTSYOKOTA/listing.html)
- Place of Performance
- Address: Unit 5228, Yokota AB, APO Japan, 96328-5228, Tokyo, Non-U.S., 1970001, Japan
- Record
- SN04553558-W 20170624/170622234320-e10373959d1a3c99510d7363089a78b8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |